Navigation Links
Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
Date:3/31/2008

r materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to: (i) the risk that our APTIMA HPV assay will perform poorly in this clinical trial, (ii) the risk that the APTIMA HPV assay will not be cleared for marketing in the timeframe we expect, if at all, (iii) the possibility that the market for the sale of our APTIMA HPV assay may not develop as expected, (iv) we may not be able to compete effectively with other companies already selling HPV diagnostic products or which launch such products in the future, (v) we depend on a small number of contract manufacturers and single source suppliers of raw materials, (vi) changes in third-party reimbursement policies regarding our products could adversely affect their sales, (vii) changes in government regulation affecting our products could harm our sales and increase our development costs, and (viii) litigation involving the assertion of third party patent rights could be expensive and divert management's attention, and/or result in damages or injunctive relief. The foregoing describes some, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

Contact:

Michael Watts

Senior director, investor relations and

corporate communications

<
'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
4. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
7. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
8. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
11. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 A study led by St. ... chemotherapy dose threshold below which male childhood cancer survivors ... appears in September 17 edition of the journal ... are at highest risk for reduced sperm production as ... of pre-treatment fertility preservation methods such as sperm banking. ...
(Date:9/16/2014)... CHICAGO , Sept. 16, 2014 The ... submitted survey data from more than 1,100 patients and ... Food and Drug Administration (FDA) for the Patient-Focused Drug ... This is a new FDA initiative to seek patient ... expectations for therapeutic treatments. "We applaud the ...
(Date:9/16/2014)... 2014 Astellas announced today it has ... & Advocacy, Urology in the Americas. Noland will report ... Margaret Long. In this role, Noland will be responsible ... and advocacy organizations, as well as collaborating with ... Noland,s appointment is the latest phase in the ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 3PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 4Christy Noland to Lead Urology Advocacy and Communications for Astellas 2
(Date:9/17/2014)... 17, 2014 U.S. News and ... the country, and three mesothelioma treatment centers made ... the mesothelioma law firm Baron and Budd ... University of Texas MD Anderson Cancer Center and ... publication. ( http://health.usnews.com/best-hospitals/rankings/cancer ) , U.S. News and ...
(Date:9/17/2014)... DMG Productions announces the upcoming ... to broadcast on Wednesday, September 24, 2014 at ... this episode, Innovations will go behind the scenes ... provide each client the opportunity to achieve the ... the principles of Care, Compassion, and Commitment. , ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Experienced dress ... making a new selection of trendy black bridesmaid dresses. ... for all its beautiful bridesmaid outfits. Readers can ... , Discount-Dress.com is a famous brand ... of new additions as well as revamped old editions, ...
(Date:9/17/2014)... Headquartered in Baltimore, Maryland, Therapy ... the country. , “The past two weeks have ... grown to over 400 evaluators in 46 states, and ... the Midwest and South Dakota and Vermont. And from ... our volunteers can visit.” , TPU provides one-of-a-kind treatment ...
(Date:9/17/2014)... Request A Test , a leading national provider of ... drug testing through the end of September 2014. ... by employers for workplace or new hire screenings. Employers ... promo code DRUG10 when placing an order. Statistics have ... especially for marijuana or THC. Request A Test offers ...
Breaking Medicine News(10 mins):Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:Therapy Pets Unlimited is Expanding 2Health News:Therapy Pets Unlimited is Expanding 3Health News:Request A Test Can Save You 10% on Drug Testing 2Health News:Request A Test Can Save You 10% on Drug Testing 3
... Heart patients and cardiologists across the country are ... access be preserved as discussions about healthcare ... for Medicare and Medicaid Services (CMS) - scheduled to ... the accessibility of life-saving cardiology testing and services currently ...
... Health System study has found that high-risk surgery ... were seen by general internists trained in managing ... underwent high-risk orthopaedic surgeries experienced shorter stays when ... surgeons. And, the study found, patients reported they ...
... true for current H1N1 strain remains a mystery, , THURSDAY, ... 1918 Spanish flu pandemic while still in their mother,s womb ... 60 years later, a new study has found. , The ... people worldwide, including 500,000 in the United States. That flu, ...
... Effort Illustrates Broad Public Support for Addressing Crisis ... Oct. 1 Citizens of Delaware ... and wellness with the launch today of "Say ,Yes, to ... video campaign of the Partnership to Fight Chronic Disease (PFCD) ...
... Pink Sheets Filings Reply To Shareholders ... General Corporate Update, , SHENZHEN, China, Oct. 1 /PRNewswire-FirstCall/ ... based operating subsidiary Mellow Hope and Serbia operating Subsidiary ... attention to today,s Pink Sheets filing. The filing found ...
... Whether they can have children is one of the ... cancer because fertility can be compromised by cancer treatment. ... studies led by researchers at Fred Hutchinson Cancer Research ... will adversely impact their newborns. The studies, presented as ...
Cached Medicine News:Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 2Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 3Health News:How to reduce hospital stays and increase patient satisfaction 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 3Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 2Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 3Health News:Hard to Treat Diseases (HTDS) Management Discussion 2Health News:Hard to Treat Diseases (HTDS) Management Discussion 3Health News:Studies find few risks to newborn offspring of parents who are childhood cancer survivors 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: